2008
DOI: 10.1681/asn.2007121377
|View full text |Cite
|
Sign up to set email alerts
|

A Bench to Bedside View of Uremic Toxins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
235
0
7

Year Published

2009
2009
2017
2017

Publication Types

Select...
4
4
2

Relationship

1
9

Authors

Journals

citations
Cited by 313 publications
(246 citation statements)
references
References 76 publications
4
235
0
7
Order By: Relevance
“…There was a higher mass removal by the renal route during the CAPD episode, however. PDI important finding, as it has been well established that uremic toxicity does not come from urea or creatinine, but rather from other substances, such as middle molecules and protein-bound solutes (18,19). Previous studies analyzing solute clearance in APD vs CAPD (20,21) all had a cross-sectional observational design so it could not be excluded that inter-individual, e.g.…”
Section: Discussionmentioning
confidence: 99%
“…There was a higher mass removal by the renal route during the CAPD episode, however. PDI important finding, as it has been well established that uremic toxicity does not come from urea or creatinine, but rather from other substances, such as middle molecules and protein-bound solutes (18,19). Previous studies analyzing solute clearance in APD vs CAPD (20,21) all had a cross-sectional observational design so it could not be excluded that inter-individual, e.g.…”
Section: Discussionmentioning
confidence: 99%
“…They have been classiied from the EuTox in difer groups according to their size and molecular weight [34]. A irst group of molecules, around 350 toxins, is composed of small uremic toxins with molecular weight below 500 Da.…”
Section: Bpa In Chronic Kidney Diseasementioning
confidence: 99%
“…2 -microglobulin, by high-flux hemodialysis is associated with a lower mortality by infectious disease (Cheung et al 2008). An increased removal of middle-sized molecules could also have positive effects of the cardiovascular system (Vanholder et al 2001;Vanholder et al 2008). In a Cochrane database review by Rabindranath et al in 2006, the authors were unable to demonstrate a significant advantage with convective therapies over low-flux hemodialysis with regard to clinical outcomes such as mortality, dialysis-related hypotension and hospitalization (Rabindranath et al 2006).…”
Section: Patients On Hemodialysismentioning
confidence: 99%